Taizo Uchimoto

4PUBLICATIONS
5CO-AUTHORS
Radiation therapyPharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Apr 20, 2026
Author's reply to 'Bayesian interpretation of febrile neutropenia risk and primary G-CSF prophylaxis during darolutamide triplet therapy'.

|Mar 12, 2026
Real-world comparison of enzalutamide and apalutamide in metastatic hormone-sensitive prostate cancer: a multi-institutional propensity score-matched analysis.

Kazuki Nishimura, Kensuke Hirosuna, Heima Niigawa

|Feb 03, 2026
Age-stratified clinical outcomes and adverse events in patients with metastatic castration-sensitive prostate cancer receiving triplet therapy with darolutamide, androgen deprivation therapy, and docetaxel.

Taizo Uchimoto, Kensuke Hirosuna, Heima Niigawa

|Oct 19, 2025
Prognostic impact of lung metastasis in patients treated with androgen receptor signaling inhibitors for castration-sensitive prostate cancer: data from the ULTRA-Japan Consortium.

Taizo Uchimoto, Kensuke Hirosuna, Heima Niigawa

Pageof 1

Frequent Collaborators

4 joint publications

Fumihiko Urabe

4 joint publications

Shunsuke Tsuzuki

4 joint publications

Kiyoshi Takahara

4 joint publications

Takahiro Kimura